Tight control is important in patients with rheumatoid arthritis treated with an anti-tumor necrosis factor biological agent: prospective study of 91 cases who used a biological agent for more than 1 year

References

• Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet. 2007;370: 1861–74.
   Google Scholar
• Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Therapeutic effect of the combination of eta-nercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomized controlled trial. Lancet. 2004;363:675–81.
   PubMed Web of Science ®Google Scholar
• Landewe R, Van der Heijde D, Klareskog L, Van Vollenhoven R, Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate. Arthritis Rheum. 2006;54:3119–25.
   PubMed Web of Science ®Google Scholar
• Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, et al. Anti-tumor necrosis factor trial in rheuma-toid arthritis with concomitant therapy study group; sustained improvement over two years in physical function. Structual damage and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum. 2004;50:1051–65.
   Google Scholar
• Smolen JS, van Der Heijde DM, St Clair EW, Emery P, Bathon JM, Keystone E, et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum. 2006;54:702–10.
   PubMed Web of Science ®Google Scholar
• van Riel PL. Provisional guidelines for measuring disease activity in RA clinical trials. Br J Rheumatol. 1992;31:793–4.
   Google Scholar
• Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–61.
   PubMed Web of Science ®Google Scholar
• Weaver AL. Efficacy and safety of the anti-TNF biological agents. Mod Rheumatol. 2004;14:101–12.
   PubMedGoogle Scholar
• American College of Rheumatology Subcommittee on Rheuma-toid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis, 2002 update. Arthritis Rheum. 2002;46:328–46.
   PubMed Web of Science ®Google Scholar
• Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the manage-ment of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34–45.
   PubMed Web of Science ®Google Scholar
• Breedvelt FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26–37.
   Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breed-veld FC, Kalden JR, et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000343: 1594–602.
   Google Scholar
• Keystone EC, Kavanaugh AF, Sharp JT, Tnannenbaum H, Hua Y, Teoh LS, et al. Radiographic, clinical, and functional out-comes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 2004;50:1400–11.
   PubMed Web of Science ®Google Scholar
• Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleisch-mann RM, Fox RI, et al. A trial of etanercept, a recombination tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340:253–9.
   Google Scholar
• van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol. 2000;27:261–3.
   PubMed Web of Science ®Google Scholar
• Larsen A, Dale K, EEK M. Radiographic evaluation of rheu-matoid arthritis and related conditions by standard reference films. Acta Radiol Diagn. 1977;18:481–91.
   Google Scholar
• Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   Google Scholar
• van der Heijde DM, van Riel PL, van Leeuwen MA, van't Hof MA, van Rijswijk MH, van de Putte LB. Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol. 1992;31: 519–22.
   Google Scholar
• Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. com-parison of disease activity score (DAS) 28-erythrocyte sedimen-tation rate and DA528-C-reactive protein threshold values. Ann Rheum Dis. 2007;66: 407–9.
   Google Scholar
• Yamanaka H, Tanaka Y, Sekiguchi N, Inoue E, Saito K, Kameda H, et al. Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM). Mod Rheumatol. 2007;17:28–32.
   PubMedGoogle Scholar
• Sano H, Arai K, Murai T, Fujisawa J, Endo N. Short-term results of etanercept in rheumatoid arthritis. Arch Niigata Soc Orthop Surg. 2007;23:51-4 (in Japanese).
   Google Scholar
• Smolen JS, Han C, Bala M, Maim RN, Kalden JR, van der Heijde D, et al. Evidence of radiographic benefit of treatment with inf-liximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement. Arthritis Rheum. 2005;52:1020–30.
   Google Scholar
• Abe A, Ishikawa H, Murasawa A, Nakazono K. Disease activity and the course of elbow joint deterioration over 10 years in the patients with early rheumatoid arthritis. Clin Rheumatol. 2007; 27:867–72.
   Google Scholar
• Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, et al. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Ann Rheum Dis. 2008;67:1153–8.
   PubMed Web of Science ®Google Scholar